Postischemic Administration of IL-1α Neutralizing Antibody Reduces Brain Damage and Neurological Deficit in Experimental Stroke
Luca Liberale(Azienda Ospedaliera di Perugia), Giovanni G. Camici(University of Zurich), Jürg H. Beer(University of Zurich), Fabrizio Montecucco(Ospedale Policlinico San Martino), Peter Libby(Harvard University), John Simard(XBiotech (United States)), Yustina M. Puspitasari(University of Zurich), Lena Schwarz(Life Science Zurich), Alexander Akhmedov(University of Zurich), Nicole R. Bonetti(University Hospital Zurich), Thomas F. Lüscher(University of Zurich), Frank Ruschitzka(Kantonsspital St. Gallen)
Cited by 37
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
Inflammation in Atherosclerosis
|Arteriosclerosis Thrombosis and Vascular Biology|2012|3.7k
Atherosclerosis
|Nature Reviews Disease Primers|2019|3k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k